Beranda › Kanker Kandung Kemih Non-Invasif Otot
Uji klinis Kanker Kandung Kemih Non-Invasif Otot yang merekrut di AS
33 studi untuk Kanker Kandung Kemih Non-Invasif Otot merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY10 studi
- Columbus, OH10 studi
- Dallas, TX10 studi
- Edison, NJ9 studi
- Myrtle Beach, SC9 studi
- Syracuse, NY8 studi
- Nashville, TN8 studi
- Baltimore, MD8 studi
- Philadelphia, PA7 studi
- Birmingham, AL7 studi
- Houston, TX7 studi
- Indianapolis, IN7 studi
- Atlanta, GA7 studi
- Austin, TX6 studi
- Los Angeles, CA6 studi
- Boston, MA6 studi
- Little Rock, AR6 studi
- San Antonio, TX6 studi
- St. Louis, MO6 studi
- Chicago, IL6 studi
- Bakersfield, CA5 studi
- Memphis, TN5 studi
- Cicero, IL5 studi
- Tampa, FL5 studi
- Durham, NC5 studi
- Staten Island, NY4 studi
- Greenburgh, NY4 studi
- East Norwalk, CT4 studi
- Queens, NY4 studi
- Seattle, WA4 studi
- Jacksonville, FL4 studi
- Pittsburgh, PA4 studi
- Lakewood, CO4 studi
- Kansas City, KS4 studi
- Washington, DC4 studi
- New Rochelle, NY3 studi
- Lafayette, LA3 studi
- Cincinnati, OH3 studi
- Phoenix, AZ3 studi
- Arlington, TX3 studi
Berdasarkan negara bagian
- Alabama7 studi
- Arizona9 studi
- Arkansas6 studi
- California15 studi
- Colorado5 studi
- Distrik Columbia4 studi
- Florida15 studi
- Georgia7 studi
- Illinois11 studi
- Indiana8 studi
- Iowa3 studi
- Kansas4 studi
- Louisiana5 studi
- Maryland8 studi
- Massachusetts10 studi
- Michigan7 studi
- Minnesota4 studi
- Missouri7 studi
- New Jersey9 studi
- New York16 studi
- North Carolina6 studi
- Ohio13 studi
- Oregon3 studi
- Pennsylvania9 studi
- South Carolina12 studi
- Tennessee10 studi
- Texas15 studi
- Virginia6 studi
- Washington5 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07309445A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06733363Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT05796375A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06503614Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07144319A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT06637423Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05951179Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
Menerima pesertaStudi observasional
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05825950Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07480356A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
Menerima pesertaFase 3
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06929286FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT05614739A Phase I Intravesical PPM Therapy for NMIBC
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05519241Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT05126472Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT07763197LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT04752722Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT07225127Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07673016A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT05710848Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
Menerima pesertaFase 2
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 17 Apr 2026 · NCT07322263In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Mar 2026 · NCT06704191Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.